CROSS-REFERENCE TO RELATED APPLICATIONS
This application claims priority under 35 U.S.C. .sctn.119 to Korean Patent Application No. 10-2014-0072542, filed on Jun. 16, 2014, in the Korean Intellectual Property Office, the disclosure of which is incorporated herein by reference in its
BACKGROUND OF THE INVENTION
The present invention relates generally to the field of radiopharmaceuticals and their use in nuclear medicine as tracers, imaging agents and for the treatment of various disease states. It is well known that tumors may express unique proteins associated with their